
UPMC Ireland Selects MEDITECH Expanse as the Cornerstone of its Digital Strategy
CANTON, Mass.--(BUSINESS WIRE)-- UPMC Ireland announced today it will implement MEDITECH Expanse as the foundational EHR of its 'once in a generation' digital transformation that will improve patient care, streamline operations, and support future innovation.
UPMC Ireland has selected @MEDITECH #Expanse as the cornerstone of its digital transformation. This will connect hospitals, cancer centres, and clinics through a single EHR—improving patient care, safety, and efficiency. @UPMCinIreland @MEDITECH_UK
The renowned global healthcare provider selected Expanse to deliver a single, shared, intelligent platform across its 4 hospitals, 2 cancer centres, and 6 sports medicine clinics. The integrated EHR features a comprehensive set of clinical, administrative, and financial solutions that will enable faster, safer, and more connected care, leading to improved patient outcomes.
'This represents a transformational step forward in how we deliver care for both our patients and our people,' said UPMC Ireland Managing Director Eamonn Fitzgerald. 'By connecting every part of the patient journey through a single, secure electronic health record, we are creating a system that is safer, faster, and more efficient. This investment ensures that our clinicians and staff have access to the tools and information they need to deliver access to care to communities across the island of Ireland. This is another step in delivering life-changing medicine together.'
UMPC's move to Expanse reflects the organisation's commitment to providing patient-centric care. The Expanse implementation will establish a single patient record that shares information seamlessly between locations, enabling improved decision-making and overall care coordination. The new EHR will help UPMC meet its goals of building a better way to care and being leaders in transforming care globally.
To further support more connected care, UPMC will deploy a unified set of core evidence-based standards across facilities. They are also implementing Expanse Revenue Cycle, which will simplify and automate workflows to maximize efficiencies and boost fiscal health.
'This implementation marks a major milestone in UPMC's digital transformation, giving us a unified, cloud-based electronic health record that replaces legacy systems,' said UPMC Ireland Chief Information Officer Pat Cronin. 'It will empower clinicians and staff with faster, more connected access to information, supporting smarter decision-making and improved care coordination. Beyond enhancing patient safety and operational efficiency, this system will serve as the digital foundation for long-term innovation and scalable, data-driven care across our network.'
Expanse will further support patient engagement with the introduction of a patient portal that empowers patients by providing access to their health information, appointment details, secure messaging with providers, and questionnaires.
UPMC envisions the implementation of the Expanse web-native and cloud-based technology as a fundamental step toward achieving future growth, innovation, and collaboration across its hospitals, cancer centres, and clinics. Expanse provides the modern digital infrastructure, advanced interoperability, and flexibility needed to propel their vision forward. It also includes built-in safeguards to protect against cyberthreats, keep data and patient privacy secure, and ensure GDPR compliance.
'We are thrilled to partner with UPMC to implement Expanse and support them in their mission to always put the patient first,' said MEDITECH Ireland Managing Director Charlotte Scott. 'This is a game-changer for the organisation and the patients it cares for. The EHR will enable more connected and better care today while also positioning UPMC for future growth and innovation.'
Discover more about MEDITECH in Ireland and the UK.
About MEDITECH
MEDITECH systems have been deployed in some of Ireland's most prestigious private hospitals for over two decades. Expanse, the intelligent EHR platform you can trust, keeps health systems at the forefront of innovation and transforms care with AI-infused solutions, personalised workflows, next-level interoperability, and predictive analytics — all working together to drive better outcomes. See why organisations in 28 countries and territories have chosen Expanse to boost the productivity and satisfaction of their staff and patients. Follow us on LinkedIn, X/Twitter and Instagram, and visit: ehr.meditech.com/global/meditech-uk-ireland.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

Yahoo
8 hours ago
- Yahoo
Pittsburgh Pirates pitcher, family turn personal tragedy into positivity
children 'She was a devoted mom. She loved all of us kids the same and immensely, and so to have her in our lives was the ultimate blessing,' Pittsburgh Pirate Isaac Mattson said. Debbie Mattson lived by a simple phrase. 'See a need, fill it.' She did that, time and time again. She worked in leadership positions at her local school district as a devout Christian and long-time volunteer. She was a mother of eight and a fierce advocate for her children. 'One of our daughters had a concussion. She reached out to the neurologist, said all of this just happened. And all of a sudden, she learned about the impact test that UPMC was doing to the Pittsburgh Steelers back then. She went to the athletic director and said 'Hey, listen. You need to do this for our athletes, for our students, for our kids,' said her husband Ed Mattson. While she gave all of herself to her family and her community, she quietly battled severe depression, an illness that took everything in 2021. Debbie took her own life, leaving behind a legacy of love and generosity. 'To see her struggle was really hard for all of us, but she was such a bright light to so many, and to know she was struggling and trying to figure things out,' said Isaac Mattson. Debbie's death shattered those who loved her. For Isaac, baseball took a back seat. His once-rising career reached a low point when the Baltimore Orioles released him a year after his mother's death. 'Going through that as a family was definitely something that was tough for a lot of us. And so, in the wake of the experience that we went through, we kind of talked through what we wanted and how we wanted to kind of walk forward and step forward into that light,' Isaac said. Just like their mother, they saw a need and filled it. They started the Debra Mattson Memorial Walk. It raises money for a scholarship in her honor and for mental health organizations. For people who know the Mattsons best, it's no surprise they turned personal tragedy into service. 'You can't fix the situation, but you can do your best to make the best out of the situation, and there's no doubt the family has done that. And Isaac has had to really work to deal with all of this but he's still the same great Isaac he has always been,' his high school coach Tim McQueeney said. For Isaac, it was more than a tribute - it inspired him to find help for himself, processing his grief and finding his game again. Last year, he made his return to the majors as a Pittsburgh Pirate. 'It was at the midst of struggling on the field that I was able to kind of take those steps forward and talk about the grief that I'd gone through and not processed completely. That was a big step for me,' Isaac said. For the Mattsons, healing is a journey they walk together. It's an ongoing process, but one that honors the woman who never turned down an opportunity to help. 'We all loved her to the end and we just hope her story can help others,' Isaac said. Anyone who needs help personally or knows someone who needs help can call the Suicide Crisis number at 988. Download the FREE WPXI News app for breaking news alerts. Follow Channel 11 News on Facebook and Twitter. | Watch WPXI NOW
Yahoo
11 hours ago
- Yahoo
Cameco Reports Expected Increase in Its Share of Westinghouse 2025 Adjusted EBITDA
All amounts in Canadian dollars unless specified otherwise SASKATOON, Saskatchewan, June 06, 2025--(BUSINESS WIRE)--Cameco (TSX: CCO; NYSE: CCJ) reports an expected increase of approximately $170 million (US) in our 49% equity share of Westinghouse Electric Company's (Westinghouse) 2025 second quarter and annual adjusted EBITDA. The expected increase is tied to Westinghouse's participation in the construction project for two nuclear reactors at the Dukovany power plant in the Czech Republic. This expected increase will be taken into consideration in determining the 2025 distribution payable by Westinghouse to Cameco. In addition to the increase in adjusted EBITDA in 2025, we expect significant financial benefits for Westinghouse, as a subcontractor, over the term of the Dukovany construction project and related to the provision of the fuel fabrication services required for both reactors for a specified period. The outlook for Westinghouse's compound annual growth rate for adjusted EBITDA remains 6% to 10% over the next five years, excluding the impact of the expected $170 million (US) increase in its 2025 adjusted EBITDA. Cameco owns a 49% interest in Westinghouse and its partner, Brookfield Renewable Partners, owns the remaining 51%. Caution about forward-looking informationThis news release includes statements and information about our expectations for the future, which we refer to as forward-looking information. Forward-looking information is based on our current views, which can change significantly, and actual results and events may be significantly different from what we currently expect. Examples of forward-looking information in this news release include our expectations regarding: Westinghouse's participation in the Dukovany power plant construction project; an increase in Westinghouse's adjusted EBITDA; Westinghouse taking this increase into consideration in determining the 2025 distribution payable to Cameco; the financial benefits for Westinghouse, as subcontractor, over the term of the Dukovany construction project and the expected future growth in Westinghouse's compound annual growth rate for adjusted EBITDA. Material risks that could lead to different results include the risk that Westinghouse is not able to participate in the Dukovany construction project on a basis that achieves the currently expected benefits to Westinghouse for any reason, or that Cameco may not derive the expected increases in its share of Westinghouse's adjusted EBITDA, or that Westinghouse does not achieve the expected future annual growth in adjusted EBITDA. In presenting the forward-looking information, we have made material assumptions which may prove incorrect about Westinghouse's participation in the Dukovany construction project and related potential benefits to Westinghouse, and continuing growth in Westinghouse's compound annual growth rate for adjusted EBITDA. Non-IFRS MeasuresAdjusted EBITDA is a measure that does not have a standardized meaning or a consistent basis of calculation under International Financial Reporting Standards (a non-IFRS measure). Westinghouse's adjusted EBITDA is defined as its net income, adjusted for the impact of certain expenses, costs, charges or benefits incurred in such period which are either not indicative of underlying business performance or that impact the ability to assess the operating performance of its business. For more information regarding our use of this non-IFRS measure see our most recent annual and quarterly Management's Discussion and Analysis. ProfileCameco is one of the largest global providers of the uranium fuel needed to power a secure energy future. Our competitive position is based on our controlling ownership of the world's largest high-grade reserves and low-cost operations, as well as significant investments across the nuclear fuel cycle, including ownership interests in Westinghouse Electric Company and Global Laser Enrichment. Utilities around the world rely on Cameco to provide global nuclear fuel solutions for the generation of safe, reliable, carbon-free nuclear power. Our shares trade on the Toronto and New York stock exchanges. Our head office is in Saskatoon, Saskatchewan, Canada. As used in this news release, the terms we, us, our, the Company and Cameco mean Cameco Corporation and its subsidiaries unless otherwise indicated. View source version on Contacts Investor inquiries Cory Kos 306-716-6782 cory_kos@ Media inquiries Veronica Baker 306-385-5541 veronica_baker@ Sign in to access your portfolio
Yahoo
11 hours ago
- Yahoo
Cameco Reports Expected Increase in Its Share of Westinghouse 2025 Adjusted EBITDA
All amounts in Canadian dollars unless specified otherwise SASKATOON, Saskatchewan, June 06, 2025--(BUSINESS WIRE)--Cameco (TSX: CCO; NYSE: CCJ) reports an expected increase of approximately $170 million (US) in our 49% equity share of Westinghouse Electric Company's (Westinghouse) 2025 second quarter and annual adjusted EBITDA. The expected increase is tied to Westinghouse's participation in the construction project for two nuclear reactors at the Dukovany power plant in the Czech Republic. This expected increase will be taken into consideration in determining the 2025 distribution payable by Westinghouse to Cameco. In addition to the increase in adjusted EBITDA in 2025, we expect significant financial benefits for Westinghouse, as a subcontractor, over the term of the Dukovany construction project and related to the provision of the fuel fabrication services required for both reactors for a specified period. The outlook for Westinghouse's compound annual growth rate for adjusted EBITDA remains 6% to 10% over the next five years, excluding the impact of the expected $170 million (US) increase in its 2025 adjusted EBITDA. Cameco owns a 49% interest in Westinghouse and its partner, Brookfield Renewable Partners, owns the remaining 51%. Caution about forward-looking informationThis news release includes statements and information about our expectations for the future, which we refer to as forward-looking information. Forward-looking information is based on our current views, which can change significantly, and actual results and events may be significantly different from what we currently expect. Examples of forward-looking information in this news release include our expectations regarding: Westinghouse's participation in the Dukovany power plant construction project; an increase in Westinghouse's adjusted EBITDA; Westinghouse taking this increase into consideration in determining the 2025 distribution payable to Cameco; the financial benefits for Westinghouse, as subcontractor, over the term of the Dukovany construction project and the expected future growth in Westinghouse's compound annual growth rate for adjusted EBITDA. Material risks that could lead to different results include the risk that Westinghouse is not able to participate in the Dukovany construction project on a basis that achieves the currently expected benefits to Westinghouse for any reason, or that Cameco may not derive the expected increases in its share of Westinghouse's adjusted EBITDA, or that Westinghouse does not achieve the expected future annual growth in adjusted EBITDA. In presenting the forward-looking information, we have made material assumptions which may prove incorrect about Westinghouse's participation in the Dukovany construction project and related potential benefits to Westinghouse, and continuing growth in Westinghouse's compound annual growth rate for adjusted EBITDA. Non-IFRS MeasuresAdjusted EBITDA is a measure that does not have a standardized meaning or a consistent basis of calculation under International Financial Reporting Standards (a non-IFRS measure). Westinghouse's adjusted EBITDA is defined as its net income, adjusted for the impact of certain expenses, costs, charges or benefits incurred in such period which are either not indicative of underlying business performance or that impact the ability to assess the operating performance of its business. For more information regarding our use of this non-IFRS measure see our most recent annual and quarterly Management's Discussion and Analysis. ProfileCameco is one of the largest global providers of the uranium fuel needed to power a secure energy future. Our competitive position is based on our controlling ownership of the world's largest high-grade reserves and low-cost operations, as well as significant investments across the nuclear fuel cycle, including ownership interests in Westinghouse Electric Company and Global Laser Enrichment. Utilities around the world rely on Cameco to provide global nuclear fuel solutions for the generation of safe, reliable, carbon-free nuclear power. Our shares trade on the Toronto and New York stock exchanges. Our head office is in Saskatoon, Saskatchewan, Canada. As used in this news release, the terms we, us, our, the Company and Cameco mean Cameco Corporation and its subsidiaries unless otherwise indicated. View source version on Contacts Investor inquiries Cory Kos 306-716-6782 cory_kos@ Media inquiries Veronica Baker 306-385-5541 veronica_baker@